By JKNewsMedia Reporter
THE NIGERIAN National Petroleum Corporation (NNPC) and the Renaissance Joint Venture (JV) has contributed $300,000 to the National Hospital, Abuja, to fund maintenance of its Linear Accelerator (LINAC) Radiotherapy Machine.
The funding targets operational upkeep of the hospital’s cancer treatment facility, ensuring consistent and accurate therapy delivery, the JV stated.
The LINAC machine, originally provided by the JV in 2019 under its Corporate Social Responsibility initiative, forms part of a broader programme to enhance Nigeria’s cancer treatment ecosystem.
The project involved installation of supporting data and ancillary systems and training of healthcare personnel to operate the sophisticated equipment.
Speaking at the office of the Coordinating Minister of Health and Social Welfare in Abuja on Tuesday, the Chief Upstream Investment Officer of NNPC Upstream Investment Management Services, Engr. Oluwaseyi Omotowa, highlighted tangible outcomes of the JV’s earlier intervention.
According to Omotowa, the initiative has treated over 2,000 patients, reduced therapy costs by 80 per cent, and cut individual treatment session durations from 12 minutes to 2 minutes.
Additionally, 712 indigent patients have received subsidised care at discounts ranging from 25 to 100 per cent.
Omotowa, represented at the event by Head of Business Services, NNPC-NUIMS, Nkechi Anaedobe, described sustainability of advanced medical technology as dependent on regular maintenance.
“Recognizing this, the NNPC Limited / Renaissance JV and partners is today taking a strategic step forward,” he said.
The officer explained that the donation would facilitate timely servicing of the LINAC machine, reduce downtime, and ensure guaranteed response times.
He added that routine maintenance ensures compliance with medical standards and audits, protects the quality of care, and allows precise calibration necessary for effective radiotherapy treatment.
“As we move forward, the JV promises to continue to forge partnerships that not only address immediate healthcare needs but also build a robust foundation for future medical advancements.
Together, we are not just treating illnesses; we are fostering a healthier, more resilient nation,” Omotowa said.
Coordinating Minister of Health and Social Welfare, Dr. Muhammed Ali Pate described the donation as exemplary for other industry players.
He noted that the intervention expands access to affordable cancer treatment and complements ongoing efforts to revamp critical healthcare infrastructure.
“Your track record is truly commendable, and this gesture underscores the intentionality behind driving impactful change,” he said.
Pate emphasised that quality healthcare requires investment, noting that President Bola Tinubu’s renewed focus on the health sector benefits from partnerships with private actors such as NNPC and Renaissance.
Chief Medical Director (CMD) of the National Hospital, Muhammad Raji Mahmud, characterised the contribution as a lifeline for the thousands of cancer patients reliant on the hospital each year.
He said the support has reduced dependence on medical tourism and strengthened national capacity for cancer care. “At National Hospital Cancer Centre, we treat thousands of patients annually, and the impact of this support has been profound.
“The backing from NNPC Limited and Renaissance has significantly bolstered in-country cancer care,” Mahmud said.
Managing Director and Chief Executive Officer (MD/CEO) of Renaissance Africa Energy Company, Tony Attah, reaffirmed the company’s commitment to sustainable healthcare.
He described the donation as a strategic investment rather than charity, designed to protect lives, advance research, and strengthen Nigeria’s health system.
“Renaissance recognises that when people are healthy, they can contribute meaningfully to their families, the communities, and the nation at large,” Attah said.
The LINAC Radiotherapy Machine remains a central element in Nigeria’s domestic cancer treatment capabilities.
Installed under the JV’s 2019 initiative, it represents a significant step in improving patient outcomes through modern technology and trained personnel.
The $300,000 maintenance funding ensures continued operational efficiency and aligns with the JV’s ongoing corporate social responsibility objectives, the release noted.
According to Omotowa, the funding covers preventive and corrective maintenance, guaranteeing uninterrupted service for patients.
The machine’s calibration and adherence to medical standards are essential for the precision required in radiotherapy.
The intervention reflects the JV’s wider strategy to create lasting impact in healthcare, particularly for vulnerable populations who benefit from subsidised or fully covered treatment.
Dr. Pate emphasised that private sector participation remains vital to expanding quality healthcare across Nigeria.
The National Hospital, Abuja, continues to serve as a hub for advanced treatment, and partnerships with energy and industrial actors are increasingly shaping the sector’s development.
The issued press release by the NNPC underlined that the donation strengthens national cancer care infrastructure while promoting affordability, accessibility, and continuity of service.
It ensures that the LINAC machine remains operational at critical times, directly benefiting thousands of patients annually.
The companies confirmed that the initiative aligns with broader objectives of enhancing medical service delivery and fostering sustainable, resilient health systems.
Both organisations also reiterated their dedication to advancing healthcare technology, supporting research, and addressing the immediate needs of patients nationwide.
They said their contribution further cements the JV’s role in Nigeria’s health sector, particularly in oncology, where equipment maintenance and precision treatment are crucial, adding that through such partnerships, the organisations aim to support national healthcare priorities, improve patient care standards, and facilitate long-term improvements in service delivery.
They also noted that the ongoing investment in technology and healthcare expertise remains central to reducing medical tourism, strengthening national capacity, and ensuring equitable access to essential treatment across Nigeria.
